Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2020

Dec 18, 2020

29831_dirs_2020-12-17_299a14fe-e071-45dd-ad30-c5b2ad82b5e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-12-16

Reporting Person: Hwang Angela (Group President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-16 Common Stock I 12970.0000 $37.8400 Acquired 26697.0000 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 20241.0000 Direct
Common Stock 8532.0000 Indirect

Footnotes

F1: This transaction constitutes an intra-plan transfer into the Pfizer Inc. stock fund under the Pfizer's Qualified Savings Plan.

F2: The reporting person disclaims beneficial ownership of the shares held by spouse.